Search research articles
Contact Us
Filters
Showing results (1-10 of 7) with videos related to
Page
of 1
Sort By:
Mutagenesis
|
June 25, 2016
Differential genotoxicity of acrylamide in the micronucleus and Pig-a gene mutation assays in F344 rats and B6C3F1 mice
Cheryl A Hobbs, Jeffrey Davis, Kim Shepard, et al.
Plos One
|
August 28, 2015
Impact of Genomics Platform and Statistical Filtering on Transcriptional Benchmark Doses (BMD) and Multiple Approaches for Selection of Chemical Point of Departure (PoD)
A Francina Webster, Nikolai Chepelev, Rémi Gagné, et al.
Chemosphere
|
August 18, 2010
Background bisphenol A in experimental materials and its implication to low-dose in vitro study
Xu-Liang Cao, Jeannette Corriveau, Svetlana Popovic, et al.
Environmental and Molecular Mutagenesis
|
November 8, 2022
Establishing a quantitative framework for regulatory interpretation of genetic toxicity dose-response data: Margin of exposure case study of 48 compounds with both in vivo mutagenicity and carcinogenicity dose-response data
Nikolai Chepelev, Alexandra S Long, Marc Beal, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA
|
January 21, 2021
Transcriptomic pathway and benchmark dose analysis of Bisphenol A, Bisphenol S, Bisphenol F, and 3,3',5,5'-Tetrabromobisphenol A in H9 human embryonic stem cells
Vian Peshdary, Cheryl A Hobbs, Timothy Maynor, et al.
Environmental and Molecular Mutagenesis
|
April 5, 2025
Benchmark Response (BMR) Values for In Vivo Mutagenicity Endpoints
Paul A White, Guangchao Chen, Nikolai Chepelev, et al.
Critical Reviews in Toxicology
|
January 22, 2015
Comparison of toxicogenomics and traditional approaches to inform mode of action and points of departure in human health risk assessment of benzo[a]pyrene in drinking water
Ivy Moffat, Nikolai Chepelev, Sarah Labib, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 7) with videos related to
Sort By:
Page
of 1
Mutagenesis
|
June 25, 2016
Differential genotoxicity of acrylamide in the micronucleus and Pig-a gene mutation assays in F344 rats and B6C3F1 mice
Cheryl A Hobbs, Jeffrey Davis, Kim Shepard, et al.
Plos One
|
August 28, 2015
Impact of Genomics Platform and Statistical Filtering on Transcriptional Benchmark Doses (BMD) and Multiple Approaches for Selection of Chemical Point of Departure (PoD)
A Francina Webster, Nikolai Chepelev, Rémi Gagné, et al.
Chemosphere
|
August 18, 2010
Background bisphenol A in experimental materials and its implication to low-dose in vitro study
Xu-Liang Cao, Jeannette Corriveau, Svetlana Popovic, et al.
Environmental and Molecular Mutagenesis
|
November 8, 2022
Establishing a quantitative framework for regulatory interpretation of genetic toxicity dose-response data: Margin of exposure case study of 48 compounds with both in vivo mutagenicity and carcinogenicity dose-response data
Nikolai Chepelev, Alexandra S Long, Marc Beal, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA
|
January 21, 2021
Transcriptomic pathway and benchmark dose analysis of Bisphenol A, Bisphenol S, Bisphenol F, and 3,3',5,5'-Tetrabromobisphenol A in H9 human embryonic stem cells
Vian Peshdary, Cheryl A Hobbs, Timothy Maynor, et al.
Environmental and Molecular Mutagenesis
|
April 5, 2025
Benchmark Response (BMR) Values for In Vivo Mutagenicity Endpoints
Paul A White, Guangchao Chen, Nikolai Chepelev, et al.
Critical Reviews in Toxicology
|
January 22, 2015
Comparison of toxicogenomics and traditional approaches to inform mode of action and points of departure in human health risk assessment of benzo[a]pyrene in drinking water
Ivy Moffat, Nikolai Chepelev, Sarah Labib, et al.
Page
of 1